Interchangeability and substitution of biosimilars: is health technology assessment (HTA) a tool for decision-making?

Interchangeability and substitution of biosimilars: is health technology assessment (HTA) a tool for decision-making? Cad Saude Publica. 2019 Sep 16;35(9):e00087219 Authors: Ascef BO, Silva RGLD, Oliveira Júnior HA, Soárez PC PMID: 31531516 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31531516?dopt=Abstract

Source: Cadernos de Saude Publica - September 15, 2019 Category: International Medicine & Public Health Authors: Ascef BO, Silva RGLD, Oliveira Júnior HA, Soárez PC Tags: Cad Saude Publica Source Type: research

More News: International Medicine & Public Health